Cargando…
Closure or medical therapy of patent foramen ovale in cryptogenic stroke: prospective case series
BACKGROUND: Results of randomized controlled trials (RCT) do not provide definite guidance for secondary prevention after ischemic stroke (IS)/transient ischemic attack (TIA) attributed to patent foramen ovale (PFO). No recommendations can be made for patients > 60 years. We aimed to compare inte...
Autores principales: | Poli, Sven, Siebert, Elisabeth, Mbroh, Joshua, Poli, Khouloud, Krumbholz, Markus, Mengel, Annerose, Greulich, Simon, Härtig, Florian, Müller, Karin A. L., Bocksch, Wolfgang, Gawaz, Meinrad, Ziemann, Ulf, Zuern, Christine S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8015114/ https://www.ncbi.nlm.nih.gov/pubmed/33789756 http://dx.doi.org/10.1186/s42466-021-00114-3 |
Ejemplares similares
-
Percutaneous closure of a patent foramen ovale after cryptogenic stroke
por: Snijder, R. J. R., et al.
Publicado: (2017) -
Closure of patent foramen ovale for secondary prevention of cryptogenic stroke: current perspectives
por: Makhija, Rakhee R., et al.
Publicado: (2019) -
Patent foramen ovale closure
por: Amin, Zahid
Publicado: (2010) -
Patent Foramen Ovale and Cryptogenic Stroke: Integrated Management
por: Lucà, Fabiana, et al.
Publicado: (2023) -
Monitoring for atrial fibrillation prior to patent foramen ovale
closure after cryptogenic stroke
por: Diener, Hans-Christoph, et al.
Publicado: (2022)